DruDevice Integration Expertise

We support pharmaceutical R&D teams by translating drug requirements into executable needle-free delivery systems.

• Early-stage drug–device fit assessment, feasibility analysis, and development pathway definition

• Rapid prototyping and drug-device compatibility validation

• Platform-level engineering designed to accommodate multiple drug modalities, dose ranges, and long-term lifecycle strategies

DruDevice Integration Expertise

We support pharmaceutical R&D teams by translating drug requirements into executable needle-free delivery systems.

• Early-stage drug–device fit assessment, feasibility analysis, and development pathway definition

• Rapid prototyping and drug-device compatibility validation

• Platform-level engineering designed to accommodate multiple drug modalities, dose ranges, and long-term lifecycle strategies

Human Factors & Clinical-Ready Design

Our needle-free platforms are engineered not only for technical feasibility, but for real-world clinical use, regulatory submission readiness, and patient-facing execution.
We integrate human factors engineering, usability validation, and clinically informed design principles early in development—ensuring smooth transition from feasibility studies to clinical trials and downstream regulatory processes.

• Human Factors Engineering (HFE)

Designed in accordance with international usability and safety expectations to support safe, intuitive patient and clinician interaction.

• Clinical Trial Readiness

Proven support for clinical protocols, investigator training, and controlled-use scenarios across early and late-stage studies.

• Regulatory-Informed Design Approach
Device architecture developed with combination product considerations in mind, minimizing downstream redesign risk.

• Global Use-Context Awareness
Experience supporting multi-region clinical and use environments, enabling consistent usability strategies across markets.

Formulation Compatibility & Delivery Performance

We design needle-free delivery systems with a deep understanding of formulation constraints—ensuring reliable performance across diverse drug properties without altering the drug itself.

• Formulation-Aware Delivery Design

Delivery parameters are engineered around formulation characteristics (e.g., viscosity, concentration, sensitivity), preserving drug integrity while enabling consistent performance.

• Compatibility Across Drug Modalities

Experience supporting peptides, biologics, and high-value injectables—addressing formulation-specific challenges through system design rather than formulation modification.

• Performance Consistency & Repeatability
Tight control of delivery dynamics to ensure dose accuracy, reproducibility, and predictable deposition profiles across use conditions.

• CMC-Respectful Integration
Designed to integrate with existing CMC strategies, minimizing formulation risk and avoiding unnecessary changes to established drug development plans.

Manufacturing & Quality System Know-How

We apply pharmaceutical-grade manufacturing and quality system thinking to needle-free device development—ensuring programs can scale with confidence when they are ready.

• Quality-by-Design Mindset

Manufacturing processes and controls are developed with risk-based thinking, traceability, and reproducibility in mind—aligned with pharmaceutical quality expectations.

• Device Manufacturing Know-How for Drug Programs

Experience translating development-stage designs into manufacturing-ready systems while maintaining consistency, reliability, and documentation integrity.

• Combination Product–Aware Quality Systems
Quality frameworks structured to support drug–device combination products, including controlled change management and cross-functional documentation alignment.

• Scale-Up Readiness Without Premature Commitment
Manufacturing strategies designed to support progression from clinical to commercial stages without forcing early, irreversible scale decisions.

Regulatory & Combination Product Experience

We support pharmaceutical partners with regulatory-aware development practices—designed to align needle-free delivery systems with combination product expectations across global markets.

• Combination Product–Informed Development

Development activities structured with drug–device combination requirements in mind, supporting coordinated submissions without shifting regulatory ownership.

• Regulatory Pathway Awareness

Familiarity with major regulatory frameworks (e.g., FDA, EMA, NMPA) and how needle-free delivery systems are positioned within pharmaceutical-led submissions.

• Documentation & Data Alignment
Technical documentation and development data generated to integrate smoothly into partner-controlled regulatory dossiers.

• Change Management with Regulatory Discipline
Design and process changes evaluated with regulatory impact in mind, minimizing downstream submission risk and rework.

Global Deployment & Lifecycle Thinking

We design needle-free delivery platforms with long-term deployment and product lifecycle evolution in mind—supporting pharmaceutical programs beyond a single indication, market, or development phase.

• Lifecycle-Oriented Platform Strategy

Delivery platforms designed to support product evolution from early clinical programs to commercial expansion, line extensions, and lifecycle upgrades.

• Global Deployment Readiness

Experience supporting programs intended for multi-region deployment, with awareness of regional use environments, regulatory expectations, and supply considerations.

• Variant & Portfolio Thinking
Platform architectures that enable future differentiation through format variants, delivery routes, or patient segments—without restarting development from scratch.

• Long-Term Partnership Perspective
Collaboration models structured to support sustained value creation across the full drug lifecycle, rather than one-off device implementation.